| Name | Title | Contact Details |
|---|
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
Sinaiko Healthcare Consulting is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Health Care Medical Technologies, Inc. is a Sioux Falls, SD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Mid-Atlantic Dental Partners delivers dental services through a partnership with dentists who are respected in their communities.
JustRight Surgical was founded in order to address a previously unmet need: the ability for pediatric surgeons to safely and effectively perform minimally invasive surgery in pediatric patients from neonate to teenager. Up until 2010, the only devices available for use in pediatric surgery were high-powered adult-sized instruments, which cause access issues and visualization problems during procedures.